Rosalind W. Picard, Edward W. Boyer, Smartwatch biomarkers and the path to clinical use, Med, Volume 2, Issue 7, 2021, Pages 797-799, ISSN 2666-6340, https://doi.org/10.1016/j.medj.2021.06.005.
Work for a Member company and need a Member Portal account? Register here with your company email address.
July 9, 2021
Rosalind W. Picard, Edward W. Boyer, Smartwatch biomarkers and the path to clinical use, Med, Volume 2, Issue 7, 2021, Pages 797-799, ISSN 2666-6340, https://doi.org/10.1016/j.medj.2021.06.005.
Wearables have advanced from collecting consumer-quality fitness data to collecting continuous clinical-quality physiology that, when processed carefully, can identify medically significant events. In a recent issue of Nature Medicine, Dunn et al.1 described how vital signs from wearables predict clinical laboratory blood- and urine-based measurements better than vital signs measured in the clinic.